Eiger BioPharmaceuticals Inc Shares Fall 3.1% Below Previous 52-Week Low - Market Mover
The shares fell 3.1% lower than its previous 52-week low of $4.58, with trading volume lower than its 30 day average
Jan 14, 2022 by Kwhen Finance Editors
Eiger BioPharmaceuticals Inc (EIGR) shares closed 3.1% lower than its previous 52 week low, giving the company a market cap of $155M. The stock is currently down 11.6% year-to-date, down 59.5% over the past 12 months, and down 60.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%.
Trading Activity
- Trading volume this week was 47.8% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Eiger BioPharmaceuticals Inc | -3.3 | -11.6 | -59.5 | -65.8 | 0.7 |
| Dow Jones Industrial Average | -0.5 | -0.1 | 18.8 | -1.4 | 24.0 |
| S&P 500 Index | -1.4 | -0.8 | 26.0 | -1.6 | 29.9 |
| Health Care | -1.8 | -3.8 | 15.2 | -4.5 | 22.7 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -559.7%
- The company's stock price performance over the past 12 months lags the peer average by 295.3%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Eiger BioPharmaceuticals Inc | EIGR | 0 | -11.6 | -59.5 | -65.8 | 0.7 |
| Peer Avg | N/A | 4.1 | 2.5 | -15.0 | -21.5 | 16.0 |
| National Research Corp | NRC | 27.3 | -6.9 | -14.9 | -30.1 | 0.2 |
| Nymox Pharmaceutical Corp | NYMX | -11.1 | 16.9 | -45.3 | -56.0 | 63.8 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: